Data Material

ALK Medical Affairs Canada provides the resources found on this website for Canadian healthcare professionals only.

Back to Results

The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial

Journal Publication

Topic: SLIT-Tablet

Allergen: Pollen

Authors: Tilo Biedermann, MD,a Piotr Kuna, MD, PhD,b Petr Panzner, MD, PhD,c Erkka Valovirta, MD,d,e Morgan Andersson, MD,f Frederic de Blay, MD, PhD,g Dorthe Thrane, MSc,h Sanja Hald Jacobsen, MSc,h Brian Sonne Stage, MSc,h and Lone Winther, Mdi

Click to view

By clicking here, you agree to visiting a site maintained by a third party, who is solely responsible for its contents.

Short Summary: The trial demonstrated the efficacy and safety of the SQ tree SLIT-tablet compared with placebo during the BPS and TPS in adolescents and adults with birch pollen-induced ARC (EudraCT 2015-004821-15).

Back to Results

You are leaving

Vous partez

The link opens a new tab

Le lien ouvre un nouvel onglet

Data Material

The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial